Back to Authors

Annese, Rachel

Mayo Clinic

Xilio Therapeutics (United States)

Citations 1

541 ctDNA as a potential surrogate biomarker for response to combination vilastobart and atezolizumab in heavily pretreated microsatellite stable (MSS) metastatic colorectal cancer (mCRC) (NCT04896697)
Hecht, J. Randolph, Xie, Hao , Algaze, Sandra, Perez, Cesar A. , Bessudo, Alberto, Knecht, John, Vandross, Andrae Lavon, Patel, Ekta , Popejoy, Myra W., Fantini, Damiano , Annese, Rachel, Dezube, Bruce J., DeVito, Nicholas C. , Fakih, Marwan , Parikh, Aparna R. , Bekaii‐Saab, Tanios , Algaze, Sandra , Spira, Alexander I. , Jones, Jeremy C , McConnell, Scott, Davar, Diwakar

Regular and Young Investigator Award Abstracts | November 10, 2025 | Volume: No volume available | Issue: No issue available | Pages: A617-A617

10.1136/jitc-2025-sitc2025.0541 Get It